Related Experiment Video
Updated: Jul 11, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Epidemiological, clinical and therapeutic features of pediatric kala-azar
Kadivar Mohammad Rahim1, Moslehi Mohammad Ashkan
1Department of Pediatrics, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Visceral leishmaniasis (Kala-azar) in Iranian children shows seasonal peaks and common symptoms like fever and enlarged spleen. Glucantim therapy is effective, but jaundice indicates a poor prognosis.
Area of Science:
- Medical Research
- Infectious Diseases
- Pediatrics
Background:
- Kala-azar, or visceral leishmaniasis, is a significant parasitic disease endemic in southern Iran.
- Infants and children represent a vulnerable population affected by this condition.
Purpose of the Study:
- To retrospectively evaluate clinical features, laboratory findings, and treatment outcomes of visceral leishmaniasis in pediatric patients in Fars Province, Iran.
- To identify prognostic factors influencing patient outcomes.
Main Methods:
- Retrospective analysis of 367 infants and children diagnosed with visceral leishmaniasis.
- Data collection on clinical presentation, laboratory results, diagnostic tests (IFA, bone marrow smears/cultures), therapy (Glucantim), and patient outcomes (cure, relapse, mortality).
Main Results:
- A seasonal variation in cases was noted, with a peak in late winter and spring.
- Predominant clinical signs included chronic fever, pallor, weight loss, abdominal distention, and hepatosplenomegaly.
- High cure rate (96.7%) with Glucantim was observed, but relapse (8.2%) and mortality (7.3%) occurred, with jaundice and deranged liver function tests being poor prognostic indicators.
Conclusions:
- Visceral leishmaniasis in this pediatric cohort is characterized by specific clinical and laboratory findings.
- Glucantim is an effective treatment, but vigilance for relapse and adverse prognostic signs like jaundice is crucial for patient management.
Abstract:
Kala-azar (visceral leishmaniasis) is endemic in southern Iran. We retrospectively evaluated 367 infants and children with visceral leishmaniasis at hospitals affiliated to Shiraz University of Medical Sciences in Fars Province (located in the southwestern part of Iran). Seasonal variation was observed with more cases presenting in late winter, spring and a few in summer. The predominant clinical features in these patients were chronic fever, pallor, weight loss, abdominal distention, and hepatosplenomegaly. Lymphadenopathy was less common. Common laboratory abnormalities included anemia, leukopenia, thrombocytopenia, hypoalbuminemia and hypergammaglobulinemia. Liver function tests were deranged in two-thirds of patients. Immuno-fluorescence antibody (IFA) test was positive in all patients and all had positive bone marrow smears or cultures for Leishmania donovani. Patients responded well to Glucantim therapy with a cure rate of 96.7%. Relapse was observed in 8.2%(30) of patients. Mortality in this series was 7.3%. Twenty-three patients died during therapy. Jaundice and grossly deranged liver function tests were bad prognostic signs.
Related Concept Videos
Rocky Mountain Spotted Fever
Smallpox
Chickenpox
Encephalitis l: Introduction
Fungal Phylum Microsporidia
Malaria